Rodney M Donlan

Summary

Affiliation: Centers for Disease Control and Prevention
Country: USA

Publications

  1. ncbi Preventing biofilms of clinically relevant organisms using bacteriophage
    Rodney M Donlan
    Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Mail Stop C 16, 1600 Clifton Road, N E, Atlanta, GA 30333, USA
    Trends Microbiol 17:66-72. 2009
  2. ncbi Bacteriophage cocktail for the prevention of biofilm formation by Pseudomonas aeruginosa on catheters in an in vitro model system
    Weiling Fu
    Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Mail Stop C 16, 1600 Clifton Rd, Atlanta, GA 30333, USA
    Antimicrob Agents Chemother 54:397-404. 2010
  3. ncbi High-level vancomycin-resistant Staphylococcus aureus isolates associated with a polymicrobial biofilm
    Linda M Weigel
    NCID DHQP ELB MS G 08, Centers for Disease Control and Prevention, 1600 Clifton Road, N E, Atlanta, GA 30333, USA
    Antimicrob Agents Chemother 51:231-8. 2007
  4. ncbi Biofilms: microbial life on surfaces
    Rodney M Donlan
    Biofilm Laboratory, Division of Healthcare Quality Promotion, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Emerg Infect Dis 8:881-90. 2002
  5. ncbi Biofilms: survival mechanisms of clinically relevant microorganisms
    Rodney M Donlan
    Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Clin Microbiol Rev 15:167-93. 2002
  6. ncbi Structural analysis of biofilm formation by rapidly and slowly growing nontuberculous mycobacteria
    Margaret M Williams
    Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Appl Environ Microbiol 75:2091-8. 2009
  7. ncbi Chlorine inactivation of bacterial bioterrorism agents
    Laura J Rose
    Centers for Disease Control and Prevention, 1600 Clifton Rd, C16, Atlanta, GA 30333, USA
    Appl Environ Microbiol 71:566-8. 2005
  8. ncbi Using bacteriophages to reduce formation of catheter-associated biofilms by Staphylococcus epidermidis
    John J Curtin
    Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Mail Stop C-16, 1600 Clifton Road, Atlanta, GA 30333, USA
    Antimicrob Agents Chemother 50:1268-75. 2006
  9. ncbi Biofilm elimination on intravascular catheters: important considerations for the infectious disease practitioner
    Rodney M Donlan
    Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Clin Infect Dis 52:1038-45. 2011

Collaborators

Detail Information

Publications9

  1. ncbi Preventing biofilms of clinically relevant organisms using bacteriophage
    Rodney M Donlan
    Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Mail Stop C 16, 1600 Clifton Road, N E, Atlanta, GA 30333, USA
    Trends Microbiol 17:66-72. 2009
    ..Phage mixtures or engineered phages could provide effective strategies to overcome these obstacles. Lytic bacteriophages could become a new class of anti-biofilm agents...
  2. ncbi Bacteriophage cocktail for the prevention of biofilm formation by Pseudomonas aeruginosa on catheters in an in vitro model system
    Weiling Fu
    Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Mail Stop C 16, 1600 Clifton Rd, Atlanta, GA 30333, USA
    Antimicrob Agents Chemother 54:397-404. 2010
    ..These results suggest the potential of applying phages, especially phage cocktails, to the surfaces of indwelling medical devices for mitigating biofilm formation by clinically relevant bacteria...
  3. ncbi High-level vancomycin-resistant Staphylococcus aureus isolates associated with a polymicrobial biofilm
    Linda M Weigel
    NCID DHQP ELB MS G 08, Centers for Disease Control and Prevention, 1600 Clifton Road, N E, Atlanta, GA 30333, USA
    Antimicrob Agents Chemother 51:231-8. 2007
    ..The potential for interspecies transfer of antimicrobial resistance genes, including resistance to vancomycin, may be enhanced by the microenvironment of a biofilm...
  4. ncbi Biofilms: microbial life on surfaces
    Rodney M Donlan
    Biofilm Laboratory, Division of Healthcare Quality Promotion, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Emerg Infect Dis 8:881-90. 2002
    ..A greater understanding of biofilm processes should lead to novel, effective control strategies for biofilm control and a resulting improvement in patient management...
  5. ncbi Biofilms: survival mechanisms of clinically relevant microorganisms
    Rodney M Donlan
    Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Clin Microbiol Rev 15:167-93. 2002
    ..In the future, treatments may be based on inhibition of genes involved in cell attachment and biofilm formation...
  6. ncbi Structural analysis of biofilm formation by rapidly and slowly growing nontuberculous mycobacteria
    Margaret M Williams
    Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Appl Environ Microbiol 75:2091-8. 2009
    ..This indicates that M. avium is better adapted for growth in potable water systems than in laboratory incubation conditions and suggests some advantage that MAC has over RGM in low-nutrient environments...
  7. ncbi Chlorine inactivation of bacterial bioterrorism agents
    Laura J Rose
    Centers for Disease Control and Prevention, 1600 Clifton Rd, C16, Atlanta, GA 30333, USA
    Appl Environ Microbiol 71:566-8. 2005
    ..Water contaminated with spores of Bacillus anthracis spores would require further treatment...
  8. ncbi Using bacteriophages to reduce formation of catheter-associated biofilms by Staphylococcus epidermidis
    John J Curtin
    Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Mail Stop C-16, 1600 Clifton Road, Atlanta, GA 30333, USA
    Antimicrob Agents Chemother 50:1268-75. 2006
    ..epidermidis over a 24-h exposure period, suggesting the potential of bacteriophage for mitigating biofilm formation on indwelling catheters and reducing the incidence of catheter-related infections...
  9. ncbi Biofilm elimination on intravascular catheters: important considerations for the infectious disease practitioner
    Rodney M Donlan
    Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Clin Infect Dis 52:1038-45. 2011
    ..These approaches have the potential to prevent or eradicate biofilms on indwelling intravascular catheters and prevent or resolve catheter-related infections...